Familial hypercholesterolaemia trials in Slovenia

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  Where

  Ljubljana

  Age

  2 years to 100 years

  People

  195 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT05682378
• Phase 4Taking people
  Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

  Where

  Ljubljana

  Age

  18 years and over

  People

  60

  Run by

  University Medical Centre Ljubljana

  See details and how to joinNCT07581808